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Abstract
Introduction: Retinopathy of prematurity (ROP) is seriously threatening eye condition that occurs in 
premature infants. The main treatment for this disease is the indirect diode laser photocoagulation.
Objective: To present the results of the treatment of children with threshold and type 1 prethreshold retinopathy 
of prematurity, treated with indirect diode laser photocoagulation at The Department of Ophthalmology of the 
University Hospital “Aleksandrovska” for the period of June 2011 – December 2015.
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Material and Methods: In the present study we included 99 eyes of 53 infants (32 boys and 21 girls) treated 
with indirect diode laser photocoagulation (810 nm) at The Department of Ophthalmology of the University 
Hospital “Aleksandrovska”. Children are diagnosed and monitored with digital fundus camera (RetCam).
Results: The average gestational age at birth of treated children was 27.06 weeks. 34 children (64.15%) had 
birth weight <1000 g., and 19 children (35.85%) had birth weight of 1000 to 1770 g. Excellent anatomical results 
were achieved in 81 eyes (81.82%). In 18 eyes (18.18%) was observed disease progression: 2 eyes with IVA gr.; 
1 eye with IVB gr.; 3 eyes with V gr.; and 12 eyes with cicatricial retinopathy of prematurity.
Conclusion: Indirect diode laser photocoagulation is a safe and effective method to treat threshold and type 1 
prethreshold retinopathy of prematurity.
Key words: Indirect diode laser photocoagulation; Retinopathy of prematurity; premature infants, treatment.
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